Sartorius Stedim Biotech S.A. | Large-cap | Healthcare
€177.85
0.88%
| Sartorius Stedim Stock Comparison:
Sartorius Stedim vs EssilorLuxotticaSartorius Stedim vs Amplitude SurgicalSartorius Stedim vs Crossject S.ASartorius Stedim vs Visiomed Group SASartorius Stedim vs Bonyf N.VSartorius Stedim vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 744.6M
Gross Profit 356.3M 47.85%
Operating Income 141.3M 18.98%
Net Income 85.4M 11.47%
EPS (Diluted) €0.88

Balance Sheet Metrics

Total Assets 8.3B
Total Liabilities 4.3B
Shareholders Equity 4.0B
Debt to Equity 1.07

Cash Flow Metrics

Operating Cash Flow 111.3M
Free Cash Flow 54.5M

Revenue & Profitability Trend

Sartorius Stedim Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.8B2.8B3.5B2.9B1.9B
Cost of Goods Sold i1.6B1.5B1.7B1.3B906.8M
Gross Profit i1.2B1.2B1.8B1.6B1.0B
Gross Margin % i43.4%44.4%52.0%53.8%52.5%
Operating Expenses
Research & Development i144.1M129.5M132.4M110.5M84.5M
Selling, General & Administrative i648.5M616.2M611.9M531.7M391.5M
Other Operating Expenses i32.4M26.1M28.3M31.8M27.9M
Total Operating Expenses i825.0M771.8M772.6M674.0M503.9M
Operating Income i395.2M470.5M1.1B883.0M503.4M
Operating Margin % i14.2%17.0%30.2%30.6%26.4%
Non-Operating Items
Interest Income i18.9M6.2M500.0K300.0K509.0K
Interest Expense i149.6M117.0M18.6M10.4M6.8M
Other Non-Operating Income-----
Pre-tax Income i219.2M401.1M1.1B646.7M460.7M
Income Tax i40.7M89.0M250.5M232.4M122.1M
Effective Tax Rate % i18.6%22.2%22.2%35.9%26.5%
Net Income i178.5M312.1M879.9M414.3M338.6M
Net Margin % i6.4%11.2%25.2%14.4%17.7%
Key Metrics
EBITDA i704.5M695.4M1.2B1.0B600.8M
EPS (Basic) i€1.81€3.36€9.51€4.50€3.64
EPS (Diluted) i€1.81€3.36€9.51€4.50€3.64
Basic Shares Outstanding i9677729692160626921630999217682992179097
Diluted Shares Outstanding i9677729692160626921630999217682992179097

Income Statement Trend

Sartorius Stedim Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i678.9M116.6M107.1M223.6M59.8M
Short-term Investments i9.9M-25.9M13.7M10.9M
Accounts Receivable i248.5M293.8M404.6M338.9M242.9M
Inventory i684.9M882.4M1.0B783.0M471.0M
Other Current Assets65.8M66.0M89.3M63.3M59.2M
Total Current Assets i1.7B1.4B1.7B1.5B873.9M
Non-Current Assets
Property, Plant & Equipment i568.7M0599.2M484.2M395.6M
Goodwill i7.4B7.4B3.1B2.3B2.0B
Intangible Assets i1.6B1.7B876.9M684.5M571.9M
Long-term Investments-----
Other Non-Current Assets3.6M2.7M2.3M700.0K510.0K
Total Non-Current Assets i6.5B6.3B3.4B2.5B2.0B
Total Assets i8.3B7.7B5.1B4.0B2.9B
Liabilities
Current Liabilities
Accounts Payable i310.0M257.1M250.2M251.3M174.7M
Short-term Debt i64.6M79.1M23.9M40.4M24.0M
Current Portion of Long-term Debt-----
Other Current Liabilities47.4M103.1M97.2M85.3M55.5M
Total Current Liabilities i938.8M937.3M1.0B1.0B567.8M
Non-Current Liabilities
Long-term Debt i2.8B3.6B1.1B585.1M563.1M
Deferred Tax Liabilities i358.2M399.8M178.3M125.8M85.1M
Other Non-Current Liabilities-100.0K-100.0K--
Total Non-Current Liabilities i3.3B4.1B1.5B1.2B827.9M
Total Liabilities i4.2B5.1B2.6B2.2B1.4B
Equity
Common Stock i19.5M18.4M18.4M18.4M18.4M
Retained Earnings i2.5B2.4B2.2B1.4B1.2B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i4.0B2.7B2.5B1.7B1.5B
Key Metrics
Total Debt i2.9B3.7B1.1B625.5M587.1M
Working Capital i802.2M477.8M635.3M418.5M306.1M

Balance Sheet Composition

Sartorius Stedim Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i219.2M401.1M1.1B646.7M460.7M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i245.9M205.4M-351.7M-239.7M-120.9M
Operating Cash Flow i618.7M656.4M645.8M627.1M351.7M
Investing Activities
Capital Expenditures i-----
Acquisitions i0-2.2B-515.6M-141.7M-470.6M
Investment Purchases i-100.0K---324.0M-159.2M
Investment Sales i-----
Investing Cash Flow i-200.0K-2.2B-526.9M-465.2M-621.1M
Financing Activities
Share Repurchases i-1.9M----
Dividends Paid i-67.1M-132.7M-116.1M-62.7M-31.3M
Debt Issuance i17.3M2.6B566.8M74.2M334.8M
Debt Repayment i-879.2M-326.4M-174.4M-79.7M-35.3M
Financing Cash Flow i262.7M2.1B235.8M-68.3M242.9M
Free Cash Flow i475.3M272.8M181.7M377.9M416.9M
Net Change in Cash i881.2M510.0M354.7M93.6M-26.5M

Cash Flow Trend

Sartorius Stedim Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 76.84
Forward P/E 41.18
Price to Book 4.40
Price to Sales 5.96
PEG Ratio 2.02

Profitability Ratios

Profit Margin 7.78%
Operating Margin 17.32%
Return on Equity 5.69%
Return on Assets 3.44%

Financial Health

Current Ratio 1.91
Debt to Equity 73.51
Beta 0.93

Per Share Data

EPS (TTM) €2.31
Book Value per Share €40.33
Revenue per Share €29.74

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
dim17.3B76.844.405.69%7.78%73.51
EssilorLuxottica 123.5B51.903.266.44%8.74%36.58
Amplitude Surgical 297.4M310.003.141.15%1.00%126.32
Crossject S.A 85.4M--478.68%0.00%-7.88
Visiomed Group SA 53.2M57.802.103.68%6.58%32.03
Bonyf N.V 7.8M-17.50-1.38%8.02%0.00

Financial data is updated regularly. All figures are in the company's reporting currency.